Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing
Cancer cells are genomically unstable and accumulate tumor type–specific molecular aberrations, which may represent hallmarks for predicting prognosis and targets for therapy. Co-deletion of chromosomes 1p and 19q marks gliomas with an oligodendroglioma component and predicts a better prognosis and...
Saved in:
Published in | The Journal of molecular diagnostics : JMD Vol. 18; no. 5; pp. 775 - 786 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.09.2016
|
Subjects | |
Online Access | Get full text |
ISSN | 1525-1578 1943-7811 |
DOI | 10.1016/j.jmoldx.2016.06.002 |
Cover
Abstract | Cancer cells are genomically unstable and accumulate tumor type–specific molecular aberrations, which may represent hallmarks for predicting prognosis and targets for therapy. Co-deletion of chromosomes 1p and 19q marks gliomas with an oligodendroglioma component and predicts a better prognosis and response to chemotherapy. In the current study, we present a novel method to detect chromosome 1p/19q co-deletion or loss of heterozygosity (LOH) in a diagnostic setting, based on single-nucleotide polymorphism (SNP) analysis and next-generation sequencing (NGS). We selected highly polymorphic SNPs distributed evenly over both chromosome arms. To experimentally determine the sensitivity and specificity of targeted SNP analysis, we used DNAs extracted from 49 routine formalin-fixed, paraffin-embedded glioma tissues and compared the outcome with diagnostic microsatellite-based LOH analysis and calculated estimates. We show that targeted SNP analysis by NGS allows reliable detection of 1p and/or 19q deletion in a background of 70% of normal cells according to calculated outcomes, is more sensitive than microsatellite-based LOH analysis, and requires much less DNA. This specific and sensitive SNP assay is broadly applicable for simultaneous allelic imbalance analysis of multiple genomic regions and can be incorporated easily into NGS mutation analyses. The combined mutation and chromosomal imbalance analysis in a single NGS assay is suited perfectly for routine glioma diagnostics and other diagnostic molecular pathology applications. |
---|---|
AbstractList | Cancer cells are genomically unstable and accumulate tumor type–specific molecular aberrations, which may represent hallmarks for predicting prognosis and targets for therapy. Co-deletion of chromosomes 1p and 19q marks gliomas with an oligodendroglioma component and predicts a better prognosis and response to chemotherapy. In the current study, we present a novel method to detect chromosome 1p/19q co-deletion or loss of heterozygosity (LOH) in a diagnostic setting, based on single-nucleotide polymorphism (SNP) analysis and next-generation sequencing (NGS). We selected highly polymorphic SNPs distributed evenly over both chromosome arms. To experimentally determine the sensitivity and specificity of targeted SNP analysis, we used DNAs extracted from 49 routine formalin-fixed, paraffin-embedded glioma tissues and compared the outcome with diagnostic microsatellite-based LOH analysis and calculated estimates. We show that targeted SNP analysis by NGS allows reliable detection of 1p and/or 19q deletion in a background of 70% of normal cells according to calculated outcomes, is more sensitive than microsatellite-based LOH analysis, and requires much less DNA. This specific and sensitive SNP assay is broadly applicable for simultaneous allelic imbalance analysis of multiple genomic regions and can be incorporated easily into NGS mutation analyses. The combined mutation and chromosomal imbalance analysis in a single NGS assay is suited perfectly for routine glioma diagnostics and other diagnostic molecular pathology applications. |
Author | Krol, Niels M.G. van Marion, Ronald Atmodimedjo, Peggy N. Dinjens, Winand N.M. van den Bent, Martin J. Dubbink, Hendrikus J. Riegman, Peter H.J. Kros, Johan M. |
Author_xml | – sequence: 1 givenname: Hendrikus J. surname: Dubbink fullname: Dubbink, Hendrikus J. email: h.dubbink@erasmusmc.nl organization: Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands – sequence: 2 givenname: Peggy N. surname: Atmodimedjo fullname: Atmodimedjo, Peggy N. organization: Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands – sequence: 3 givenname: Ronald surname: van Marion fullname: van Marion, Ronald organization: Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands – sequence: 4 givenname: Niels M.G. surname: Krol fullname: Krol, Niels M.G. organization: Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands – sequence: 5 givenname: Peter H.J. surname: Riegman fullname: Riegman, Peter H.J. organization: Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands – sequence: 6 givenname: Johan M. surname: Kros fullname: Kros, Johan M. organization: Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands – sequence: 7 givenname: Martin J. surname: van den Bent fullname: van den Bent, Martin J. organization: Department of Neuro-Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands – sequence: 8 givenname: Winand N.M. surname: Dinjens fullname: Dinjens, Winand N.M. organization: Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands |
BookMark | eNqVUdtKAzEQDaKgVf_Ah_2BrbltdldEEC-1UPSh-hyyybRkTbOarNL-vVnrkyBFGMhMhnNmzpkR2vedB4TOCB4TTMR5O25XnTPrMU3VGKfAdA8dkZqzvKwI2U95QYucFGV1iEYxthgTzgU9QvNbq5a-i73V2S30oHvb-axbZNfOgUufsy5GiJnyJpuuGuWU16lsNtkjrPt8Ah6C-sbM4f0DvLZ-eYIOFspFOP15j9HL_d3zzUM-e5pMb65nuWa0oHlhKgGNZjUxTY2poIUpDAdoyoLXwhCNmarKmuumoqIUuuSM1VqlvhKEAWPH6GLLq0NaMsBCatt_L9MHZZ0kWA72yFZu7ZGDPRKnwDSB-S_wW7ArFTa7YFdbGCRhnxaCjNom2WBsSOZJ09n_EmhnvdXKvcIGYtt9BJ9Mk0RGKrGcD4cb7kYEw7jGg-rLvwl2z_8CX5qtCw |
CitedBy_id | crossref_primary_10_1016_j_jmoldx_2021_06_004 crossref_primary_10_1158_1078_0432_CCR_21_4283 crossref_primary_10_1136_gutjnl_2016_312608 crossref_primary_10_1016_j_jmoldx_2017_11_011 crossref_primary_10_1002_mgg3_699 crossref_primary_10_1002_ijc_33327 crossref_primary_10_1007_s11060_018_2867_8 crossref_primary_10_1007_s12282_021_01276_3 crossref_primary_10_1016_j_yexmp_2024_104920 crossref_primary_10_1177_17562848211002023 crossref_primary_10_1093_neuonc_noab088 crossref_primary_10_1016_j_humpath_2022_05_001 crossref_primary_10_1093_neuonc_now277 crossref_primary_10_1111_apm_12916 crossref_primary_10_1016_S1470_2045_21_00090_5 crossref_primary_10_1093_neuonc_nox086 crossref_primary_10_1186_s40478_018_0633_y crossref_primary_10_3389_fonc_2021_683057 crossref_primary_10_1111_neup_12672 crossref_primary_10_1158_1078_0432_CCR_19_1127 crossref_primary_10_1016_j_anndiagpath_2022_151899 crossref_primary_10_1007_s00428_019_02555_3 crossref_primary_10_1016_j_ibneur_2022_09_005 crossref_primary_10_1093_noajnl_vdaa109 crossref_primary_10_1097_PAP_0000000000000186 crossref_primary_10_1002_ijc_33853 crossref_primary_10_1002_cjp2_216 crossref_primary_10_5858_arpa_2021_0295_CP crossref_primary_10_1093_jnen_nlae011 crossref_primary_10_4103_glioma_glioma_29_19 crossref_primary_10_1007_s00428_022_03268_w crossref_primary_10_1007_s00401_017_1781_z crossref_primary_10_1111_nan_12790 crossref_primary_10_3390_cells8101186 crossref_primary_10_1177_2374289518766521 crossref_primary_10_1186_s40478_022_01466_w crossref_primary_10_1093_neuonc_nox176 crossref_primary_10_1016_j_ygyno_2019_03_003 crossref_primary_10_1097_PAP_0000000000000194 crossref_primary_10_1016_j_yexmp_2021_104621 crossref_primary_10_1080_02688697_2020_1847249 crossref_primary_10_5858_arpa_2019_0010_OA crossref_primary_10_1002_14651858_CD013387_pub2 crossref_primary_10_1134_S1022795419090023 crossref_primary_10_1093_neuonc_noz200 crossref_primary_10_1016_j_ejmg_2020_103840 crossref_primary_10_1016_j_humpath_2017_05_005 crossref_primary_10_18632_oncotarget_19103 crossref_primary_10_1093_nop_npy041 crossref_primary_10_1016_j_jmoldx_2016_08_002 crossref_primary_10_1016_S0140_6736_17_31442_3 crossref_primary_10_1093_noajnl_vdaa009 crossref_primary_10_3390_cancers11060773 crossref_primary_10_1016_j_ejca_2022_12_010 crossref_primary_10_1093_neuonc_noy048 crossref_primary_10_1002_mgg3_2098 crossref_primary_10_1007_s11060_024_04563_z crossref_primary_10_1038_modpathol_2017_187 crossref_primary_10_1186_s13104_017_2456_5 crossref_primary_10_3389_fonc_2022_861078 crossref_primary_10_5812_ans_68874 crossref_primary_10_3390_life12070956 |
Cites_doi | 10.1158/0008-5472.CAN-06-1796 10.1016/j.jmoldx.2014.09.008 10.1186/gb-2010-11-8-r86 10.1093/nar/gkq603 10.1002/path.4419 10.1101/gr.4086505 10.1200/JCO.2005.04.6078 10.1053/j.gastro.2014.08.041 10.1093/neuonc/nov182 10.1111/j.1582-4934.2009.00977.x 10.1056/NEJMoa052306 10.1200/JCO.2005.04.3414 10.1097/01.LAB.0000059948.67795.EF 10.1016/j.molonc.2014.03.004 10.1053/j.gastro.2013.12.002 10.1200/JCO.2012.43.2229 10.1016/j.jmoldx.2013.08.004 10.1093/neuonc/nop075 10.2353/jmoldx.2006.060012 10.1016/j.jmoldx.2011.05.009 10.5858/2010-0649-RAIR.1 10.5414/NPP30047 10.1038/nbt.2696 10.1093/bioinformatics/btu436 10.1016/j.jmoldx.2013.03.001 10.1016/j.jmoldx.2014.12.006 10.1200/JCO.2009.24.1034 |
ContentType | Journal Article |
Copyright | 2016 American Society for Investigative Pathology and the Association for Molecular Pathology American Society for Investigative Pathology and the Association for Molecular Pathology |
Copyright_xml | – notice: 2016 American Society for Investigative Pathology and the Association for Molecular Pathology – notice: American Society for Investigative Pathology and the Association for Molecular Pathology |
DBID | AAYXX CITATION |
DOI | 10.1016/j.jmoldx.2016.06.002 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1943-7811 |
EndPage | 786 |
ExternalDocumentID | 10_1016_j_jmoldx_2016_06_002 S1525157816300903 1_s2_0_S1525157816300903 |
GroupedDBID | --- --K .1- .55 .FO .GJ 0R~ 18M 1KJ 1P~ 29L 2WC 34G 39C 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 AAEDT AAEDW AAIKJ AALRI AAQFI AAQXK AAXUO AAYWO ABJNI ABLJU ABMAC ABOCM ABWVN ACGFS ACRPL ACVFH ADBBV ADCNI ADEZE ADHJS ADMUD ADNMO ADVLN AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AGCQF AGHFR AGQPQ AI. AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP ASPBG AVWKF AZFZN BAWUL BELOY CS3 DIK DU5 E3Z EBS EFKBS EJD F5P FDB FEDTE FGOYB FRP GBLVA GX1 H13 HVGLF HX~ HZ~ IH2 IXB M41 O9- OG0 OK1 OS0 P2P R2- ROL SEL SES SJN SSZ TIP TR2 VH1 WH7 WOQ X7M XH2 YHG Z5R ADPAM AFCTW NCXOZ VXZ AAIAV AGZHU AHPSJ ALXNB ZA5 AAYXX CITATION |
ID | FETCH-LOGICAL-c3252-5d86ebc391db902625d5d4eeb75496d1c03a8794cb82676c74339caeb7a613e33 |
IEDL.DBID | IXB |
ISSN | 1525-1578 |
IngestDate | Tue Jul 01 04:02:34 EDT 2025 Thu Apr 24 22:52:31 EDT 2025 Fri Feb 23 02:31:44 EST 2024 Tue Feb 25 19:55:53 EST 2025 Tue Aug 26 16:34:00 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | This article is made available under the Elsevier license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3252-5d86ebc391db902625d5d4eeb75496d1c03a8794cb82676c74339caeb7a613e33 |
OpenAccessLink | https://www.clinicalkey.com/#!/content/1-s2.0-S1525157816300903 |
PageCount | 12 |
ParticipantIDs | crossref_citationtrail_10_1016_j_jmoldx_2016_06_002 crossref_primary_10_1016_j_jmoldx_2016_06_002 elsevier_sciencedirect_doi_10_1016_j_jmoldx_2016_06_002 elsevier_clinicalkeyesjournals_1_s2_0_S1525157816300903 elsevier_clinicalkey_doi_10_1016_j_jmoldx_2016_06_002 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-09 |
PublicationDateYYYYMMDD | 2016-09-01 |
PublicationDate_xml | – month: 09 year: 2016 text: 2016-09 |
PublicationDecade | 2010 |
PublicationTitle | The Journal of molecular diagnostics : JMD |
PublicationYear | 2016 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | van den Bent, Brandes, Taphoorn, Kros, Kouwenhoven, Delattre, Bernsen, Frenay, Tijssen, Grisold, Sipos, Enting, French, Dinjens, Vecht, Allgeier, Lacombe, Gorlia, Hoang-Xuan (bib8) 2013; 31 Hatanpaa, Burger, Eshleman, Murphy, Berg (bib10) 2003; 83 Geurts-Giele, Leenen, Dubbink, Meijssen, Post, Sleddens, Kuipers, Goverde, van den Ouweland, van Lier, Steyerberg, van Leerdam, Wagner, Dinjens (bib24) 2014; 234 Harada, Henderson, Eshleman, Gocke, Burger, Griffin, Batista (bib12) 2011; 13 Piccart-Gebhart, Procter, Leyland-Jones, Goldhirsch, Untch, Smith, Gianni, Baselga, Bell, Jackisch, Cameron, Dowsett, Barrios, Steger, Huang, Andersson, Inbar, Lichinitser, Lang, Nitz, Iwata, Thomssen, Lohrisch, Suter, Ruschoff, Suto, Greatorex, Ward, Straehle, McFadden, Dolci, Gelber (bib3) 2005; 353 Dubbink, Atmodimedjo, Kros, French, Sanson, Idbaih, Wesseling, Enting, Spliet, Tijssen, Dinjens, Gorlia, van den Bent (bib23) 2016; 18 Jenkins, Blair, Ballman, Giannini, Arusell, Law, Flynn, Passe, Felten, Brown, Shaw, Buckner (bib5) 2006; 66 Dubbink, Deans, Tops, van Kemenade, Koljenovic, van Krieken, Blokx, Dinjens, Groenen (bib1) 2014; 8 Vogazianou, Chan, Backlund, Pearson, Liu, Langford, Gregory, Collins, Ichimura (bib6) 2010; 12 Cairncross, Berkey, Shaw, Jenkins, Scheithauer, Brachman, Buckner, Fink, Souhami, Laperierre, Mehta, Curran (bib7) 2006; 24 Nikiforova, Hamilton (bib13) 2011; 135 van Lier, Wagner, van Leerdam, Biermann, Kuipers, Steyerberg, Dubbink, Dinjens (bib21) 2010; 14 Haraldsdottir, Hampel, Tomsic, Frankel, Pearlman, de la Chapelle, Pritchard (bib29) 2014; 147 Boeva, Popova, Lienard, Toffoli, Kamal, Le Tourneau, Gentien, Servant, Gestraud, Rio Frio, Hupe, Barillot, Laes (bib15) 2014; 30 Grasso, Butler, Rhodes, Quist, Neff, Moore, Tomlins, Reinig, Beadling, Andersen, Corless (bib17) 2015; 17 Mensenkamp, Vogelaar, van Zelst-Stams, Goossens, Ouchene, Hendriks-Cornelissen, Kwint, Hoogerbrugge, Nagtegaal, Ligtenberg (bib28) 2014; 146 (accessed July 25, 2016). Federation of Medical Scientific Societies: Human tissue and medical research: code of conduct for responsible use (2011). Available at Goecks, Nekrutenko, Taylor, Galaxy (bib26) 2010; 11 Cheng, Mitchell, Zehir, Shah, Benayed, Syed, Chandramohan, Liu, Won, Scott, Brannon, O'Reilly, Sadowska, Casanova, Yannes, Hechtman, Yao, Song, Ross, Oultache, Dogan, Borsu, Hameed, Nafa, Arcila, Ladanyi, Berger (bib18) 2015; 17 Wang, Li, Hakonarson (bib27) 2010; 38 Lindeman, Cagle, Beasley, Chitale, Dacic, Giaccone, Jenkins, Kwiatkowski, Saldivar, Squire, Thunnissen, Ladanyi (bib2) 2013; 15 van den Bent, Dubbink, Sanson, van der Lee-Haarloo, Hegi, Jeuken, Ibdaih, Brandes, Taphoorn, Frenay, Lacombe, Gorlia, Dinjens, Kros (bib22) 2009; 27 Frampton, Fichtenholtz, Otto, Wang, Downing, He (bib14) 2013; 31 Woehrer, Sander, Haberler, Kern, Maier, Preusser, Hartmann, Kros, Hainfellner (bib9) 2011; 30 Giardine, Riemer, Hardison, Burhans, Elnitski, Shah, Zhang, Blankenberg, Albert, Taylor, Miller, Kent, Nekrutenko (bib25) 2005; 15 van den Bent, Carpentier, Brandes, Sanson, Taphoorn, Bernsen, Frenay, Tijssen, Grisold, Sipos, Haaxma-Reiche, Kros, van Kouwenhoven, Vecht, Allgeier, Lacombe, Gorlia (bib19) 2006; 24 Reifenberger, Reifenberger, Liu, James, Wechsler, Collins (bib4) 1994; 145 Jeuken, Cornelissen, Boots-Sprenger, Gijsen, Wesseling (bib11) 2006; 8 Pritchard, Salipante, Koehler, Smith, Scroggins, Wood, Wu, Lee, Dintzis, Adey, Liu, Eaton, Martins, Stricker, Margolin, Hoffman, Churpek, Tait, King, Walsh (bib16) 2014; 16 Mensenkamp (10.1016/j.jmoldx.2016.06.002_bib28) 2014; 146 Pritchard (10.1016/j.jmoldx.2016.06.002_bib16) 2014; 16 Goecks (10.1016/j.jmoldx.2016.06.002_bib26) 2010; 11 Woehrer (10.1016/j.jmoldx.2016.06.002_bib9) 2011; 30 Geurts-Giele (10.1016/j.jmoldx.2016.06.002_bib24) 2014; 234 Boeva (10.1016/j.jmoldx.2016.06.002_bib15) 2014; 30 Harada (10.1016/j.jmoldx.2016.06.002_bib12) 2011; 13 Giardine (10.1016/j.jmoldx.2016.06.002_bib25) 2005; 15 van Lier (10.1016/j.jmoldx.2016.06.002_bib21) 2010; 14 Cairncross (10.1016/j.jmoldx.2016.06.002_bib7) 2006; 24 van den Bent (10.1016/j.jmoldx.2016.06.002_bib8) 2013; 31 Jeuken (10.1016/j.jmoldx.2016.06.002_bib11) 2006; 8 Vogazianou (10.1016/j.jmoldx.2016.06.002_bib6) 2010; 12 Piccart-Gebhart (10.1016/j.jmoldx.2016.06.002_bib3) 2005; 353 10.1016/j.jmoldx.2016.06.002_bib20 Dubbink (10.1016/j.jmoldx.2016.06.002_bib1) 2014; 8 Jenkins (10.1016/j.jmoldx.2016.06.002_bib5) 2006; 66 Wang (10.1016/j.jmoldx.2016.06.002_bib27) 2010; 38 Frampton (10.1016/j.jmoldx.2016.06.002_bib14) 2013; 31 van den Bent (10.1016/j.jmoldx.2016.06.002_bib22) 2009; 27 Hatanpaa (10.1016/j.jmoldx.2016.06.002_bib10) 2003; 83 Reifenberger (10.1016/j.jmoldx.2016.06.002_bib4) 1994; 145 Haraldsdottir (10.1016/j.jmoldx.2016.06.002_bib29) 2014; 147 Nikiforova (10.1016/j.jmoldx.2016.06.002_bib13) 2011; 135 van den Bent (10.1016/j.jmoldx.2016.06.002_bib19) 2006; 24 Cheng (10.1016/j.jmoldx.2016.06.002_bib18) 2015; 17 Lindeman (10.1016/j.jmoldx.2016.06.002_bib2) 2013; 15 Dubbink (10.1016/j.jmoldx.2016.06.002_bib23) 2016; 18 Grasso (10.1016/j.jmoldx.2016.06.002_bib17) 2015; 17 |
References_xml | – volume: 145 start-page: 1175 year: 1994 end-page: 1190 ident: bib4 article-title: Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p publication-title: Am J Pathol – volume: 24 start-page: 2707 year: 2006 end-page: 2714 ident: bib7 article-title: Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402 publication-title: J Clin Oncol – volume: 24 start-page: 2715 year: 2006 end-page: 2722 ident: bib19 article-title: Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial publication-title: J Clin Oncol – volume: 30 start-page: 47 year: 2011 end-page: 55 ident: bib9 article-title: FISH-based detection of 1p 19q codeletion in oligodendroglial tumors: procedures and protocols for neuropathological practice - a publication under the auspices of the Research Committee of the European Confederation of Neuropathological Societies (Euro-CNS) publication-title: Clin Neuropathol – volume: 17 start-page: 251 year: 2015 end-page: 264 ident: bib18 article-title: Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology publication-title: J Mol Diagn – volume: 16 start-page: 56 year: 2014 end-page: 67 ident: bib16 article-title: Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens publication-title: J Mol Diagn – volume: 66 start-page: 9852 year: 2006 end-page: 9861 ident: bib5 article-title: A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma publication-title: Cancer Res – reference: Federation of Medical Scientific Societies: Human tissue and medical research: code of conduct for responsible use (2011). Available at – volume: 8 start-page: 830 year: 2014 end-page: 839 ident: bib1 article-title: Next generation diagnostic molecular pathology: critical appraisal of quality assurance in Europe publication-title: Mol Oncol – volume: 15 start-page: 1451 year: 2005 end-page: 1455 ident: bib25 article-title: Galaxy: a platform for interactive large-scale genome analysis publication-title: Genome Res – volume: 15 start-page: 415 year: 2013 end-page: 453 ident: bib2 article-title: Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology publication-title: J Mol Diagn – volume: 38 start-page: e164 year: 2010 ident: bib27 article-title: ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data publication-title: Nucleic Acids Res – reference: (accessed July 25, 2016). – volume: 8 start-page: 433 year: 2006 end-page: 443 ident: bib11 article-title: Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors publication-title: J Mol Diagn – volume: 18 start-page: 388 year: 2016 end-page: 400 ident: bib23 article-title: Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial publication-title: Neuro Oncol – volume: 12 start-page: 664 year: 2010 end-page: 678 ident: bib6 article-title: Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses publication-title: Neuro Oncol – volume: 11 start-page: R86 year: 2010 ident: bib26 article-title: Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences publication-title: Genome Biol – volume: 30 start-page: 3443 year: 2014 end-page: 3450 ident: bib15 article-title: Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data publication-title: Bioinformatics – volume: 31 start-page: 344 year: 2013 end-page: 350 ident: bib8 article-title: Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951 publication-title: J Clin Oncol – volume: 83 start-page: 419 year: 2003 end-page: 428 ident: bib10 article-title: Molecular diagnosis of oligodendroglioma in paraffin sections publication-title: Lab Invest – volume: 353 start-page: 1659 year: 2005 end-page: 1672 ident: bib3 article-title: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer publication-title: N Engl J Med – volume: 234 start-page: 548 year: 2014 end-page: 559 ident: bib24 article-title: Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers publication-title: J Pathol – volume: 31 start-page: 1023 year: 2013 end-page: 1031 ident: bib14 article-title: Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing publication-title: Nat Biotechnol – volume: 146 start-page: 643 year: 2014 end-page: 646.e8 ident: bib28 article-title: Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors publication-title: Gastroenterology – volume: 147 start-page: 1308 year: 2014 end-page: 1316.e1 ident: bib29 article-title: Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations publication-title: Gastroenterology – volume: 135 start-page: 558 year: 2011 end-page: 568 ident: bib13 article-title: Molecular diagnostics of gliomas publication-title: Arch Pathol Lab Med – volume: 17 start-page: 53 year: 2015 end-page: 63 ident: bib17 article-title: Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data publication-title: J Mol Diagn – volume: 14 start-page: 181 year: 2010 end-page: 197 ident: bib21 article-title: A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory publication-title: J Cell Mol Med – volume: 27 start-page: 5881 year: 2009 end-page: 5886 ident: bib22 article-title: MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951 publication-title: J Clin Oncol – volume: 13 start-page: 541 year: 2011 end-page: 548 ident: bib12 article-title: Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: superior results compared with microsatellite analysis publication-title: J Mol Diagn – volume: 66 start-page: 9852 year: 2006 ident: 10.1016/j.jmoldx.2016.06.002_bib5 article-title: A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-1796 – volume: 17 start-page: 53 year: 2015 ident: 10.1016/j.jmoldx.2016.06.002_bib17 article-title: Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data publication-title: J Mol Diagn doi: 10.1016/j.jmoldx.2014.09.008 – volume: 11 start-page: R86 year: 2010 ident: 10.1016/j.jmoldx.2016.06.002_bib26 article-title: Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences publication-title: Genome Biol doi: 10.1186/gb-2010-11-8-r86 – volume: 38 start-page: e164 year: 2010 ident: 10.1016/j.jmoldx.2016.06.002_bib27 article-title: ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data publication-title: Nucleic Acids Res doi: 10.1093/nar/gkq603 – volume: 234 start-page: 548 year: 2014 ident: 10.1016/j.jmoldx.2016.06.002_bib24 article-title: Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers publication-title: J Pathol doi: 10.1002/path.4419 – volume: 15 start-page: 1451 year: 2005 ident: 10.1016/j.jmoldx.2016.06.002_bib25 article-title: Galaxy: a platform for interactive large-scale genome analysis publication-title: Genome Res doi: 10.1101/gr.4086505 – volume: 24 start-page: 2715 year: 2006 ident: 10.1016/j.jmoldx.2016.06.002_bib19 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.04.6078 – volume: 147 start-page: 1308 year: 2014 ident: 10.1016/j.jmoldx.2016.06.002_bib29 article-title: Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations publication-title: Gastroenterology doi: 10.1053/j.gastro.2014.08.041 – volume: 18 start-page: 388 year: 2016 ident: 10.1016/j.jmoldx.2016.06.002_bib23 article-title: Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial publication-title: Neuro Oncol doi: 10.1093/neuonc/nov182 – volume: 14 start-page: 181 year: 2010 ident: 10.1016/j.jmoldx.2016.06.002_bib21 article-title: A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory publication-title: J Cell Mol Med doi: 10.1111/j.1582-4934.2009.00977.x – volume: 353 start-page: 1659 year: 2005 ident: 10.1016/j.jmoldx.2016.06.002_bib3 article-title: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa052306 – volume: 145 start-page: 1175 year: 1994 ident: 10.1016/j.jmoldx.2016.06.002_bib4 article-title: Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p publication-title: Am J Pathol – volume: 24 start-page: 2707 year: 2006 ident: 10.1016/j.jmoldx.2016.06.002_bib7 article-title: Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.04.3414 – volume: 83 start-page: 419 year: 2003 ident: 10.1016/j.jmoldx.2016.06.002_bib10 article-title: Molecular diagnosis of oligodendroglioma in paraffin sections publication-title: Lab Invest doi: 10.1097/01.LAB.0000059948.67795.EF – volume: 8 start-page: 830 year: 2014 ident: 10.1016/j.jmoldx.2016.06.002_bib1 article-title: Next generation diagnostic molecular pathology: critical appraisal of quality assurance in Europe publication-title: Mol Oncol doi: 10.1016/j.molonc.2014.03.004 – volume: 146 start-page: 643 year: 2014 ident: 10.1016/j.jmoldx.2016.06.002_bib28 article-title: Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.12.002 – volume: 31 start-page: 344 year: 2013 ident: 10.1016/j.jmoldx.2016.06.002_bib8 article-title: Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951 publication-title: J Clin Oncol doi: 10.1200/JCO.2012.43.2229 – volume: 16 start-page: 56 year: 2014 ident: 10.1016/j.jmoldx.2016.06.002_bib16 article-title: Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens publication-title: J Mol Diagn doi: 10.1016/j.jmoldx.2013.08.004 – volume: 12 start-page: 664 year: 2010 ident: 10.1016/j.jmoldx.2016.06.002_bib6 article-title: Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses publication-title: Neuro Oncol doi: 10.1093/neuonc/nop075 – volume: 8 start-page: 433 year: 2006 ident: 10.1016/j.jmoldx.2016.06.002_bib11 article-title: Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors publication-title: J Mol Diagn doi: 10.2353/jmoldx.2006.060012 – volume: 13 start-page: 541 year: 2011 ident: 10.1016/j.jmoldx.2016.06.002_bib12 article-title: Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: superior results compared with microsatellite analysis publication-title: J Mol Diagn doi: 10.1016/j.jmoldx.2011.05.009 – volume: 135 start-page: 558 year: 2011 ident: 10.1016/j.jmoldx.2016.06.002_bib13 article-title: Molecular diagnostics of gliomas publication-title: Arch Pathol Lab Med doi: 10.5858/2010-0649-RAIR.1 – volume: 30 start-page: 47 year: 2011 ident: 10.1016/j.jmoldx.2016.06.002_bib9 publication-title: Clin Neuropathol doi: 10.5414/NPP30047 – volume: 31 start-page: 1023 year: 2013 ident: 10.1016/j.jmoldx.2016.06.002_bib14 article-title: Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing publication-title: Nat Biotechnol doi: 10.1038/nbt.2696 – ident: 10.1016/j.jmoldx.2016.06.002_bib20 – volume: 30 start-page: 3443 year: 2014 ident: 10.1016/j.jmoldx.2016.06.002_bib15 article-title: Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data publication-title: Bioinformatics doi: 10.1093/bioinformatics/btu436 – volume: 15 start-page: 415 year: 2013 ident: 10.1016/j.jmoldx.2016.06.002_bib2 publication-title: J Mol Diagn doi: 10.1016/j.jmoldx.2013.03.001 – volume: 17 start-page: 251 year: 2015 ident: 10.1016/j.jmoldx.2016.06.002_bib18 article-title: Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology publication-title: J Mol Diagn doi: 10.1016/j.jmoldx.2014.12.006 – volume: 27 start-page: 5881 year: 2009 ident: 10.1016/j.jmoldx.2016.06.002_bib22 article-title: MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951 publication-title: J Clin Oncol doi: 10.1200/JCO.2009.24.1034 |
SSID | ssj0014462 |
Score | 2.1256726 |
Snippet | Cancer cells are genomically unstable and accumulate tumor type–specific molecular aberrations, which may represent hallmarks for predicting prognosis and... |
SourceID | crossref elsevier |
SourceType | Enrichment Source Index Database Publisher |
StartPage | 775 |
SubjectTerms | Pathology |
Title | Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1525157816300903 https://www.clinicalkey.es/playcontent/1-s2.0-S1525157816300903 https://dx.doi.org/10.1016/j.jmoldx.2016.06.002 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La8JAEF6sh9JL6ZPah-yh16CbTWJytFr7oHqxgrdlXwElJlIttP--s5uNWCwIPWYzQ8IwO4-db2YRuqeCRxpCBc9PpO8FUlOPg2P1aOpz43KklOYccjiKnifB6zSc1lCv6oUxsEpn-0ubbq21W2k5abaWs1lrbG7uIaBwxEyNSuzET9NVapr4pg-bSgKkO7biCcSeoa7a5yzGa74oMvVlAF6RneLpDld23NOWyxmcoGMXK-Ju-TunqKbzM3Q4dNXwczTulzg5eI37em1BVTkuUtzNMp3B4lthSrqY5wq_LIQBMYJVwOIbj0y-W06ctjzjElANbuwCTQaP771nz12S4Enqh5BIqjjSQtKEKJFAQuWHKlSB1qIDmV-kiGxTHsOmkwISiU4kIWKgieTwnkfmBJReonpe5PoKYRXE4DHTNCApDSJNYiCScaBpotqKp7SBaCUbJt0EcXORRcYqqNiclRJlRqLMIub8BvI2XMtygsYe-rASO6u6Q8GeMTDxe_g6f_HplduUK0bYymdttqM425y_dG_vN6__zXmDjsxTiVa7RfX1x6e-g_BmLZro4GlKmlaLfwCJOfls |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da8IwEA-ywbaXsU_mPvOw16Bt2to-Op3opr6o4FtIkxSU2sp0sP33uzSpOBwIe03uaDku95H73QWhZxrzQEGoQNxIuMQTihIOjpXQxOXa5Qgh9D3kYBh0J97b1J9WUKvshdGwSmv7jU0vrLVdqVlp1pazWW2kX-5xQOEcPTUq0hM_DyEaqGvV7k1fNqUEyHeKkidQE01e9s8VIK_5Ik_ll0Z4BcUYT3u7suOftnxO5wyd2mARN83_nKOKyi7Q0cCWwy_RqG2AcrCN22pdoKoynCe4maYqhcV-rmu6mGcS9xaxRjGCWcDxNx7qhNeMnC54RgZRDX7sCk06r-NWl9hXEoigrg-ZpAwDFQsaOTKOIKNyfelLT6m4AalfIB1RpzyEUydiyCQagYCQgUaCwz4P9BUovUYHWZ6pG4SlF4LLTBLPSagXKCcEIhF6ikayLnlCq4iWsmHCjhDXL1mkrMSKzZmRKNMSZQVkzq0isuFamhEae-j9UuysbA8Fg8bAxu_ha_zFp1b2VK6Yw1Yuq7Mdzdnm_KV8e795-2_OJ3TcHQ_6rN8bvt-hE71joGv36GD98akeINZZx4-FLv8AP7z7ng |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnostic+Detection+of+Allelic+Losses+and+Imbalances+by+Next-Generation+Sequencing&rft.jtitle=The+Journal+of+molecular+diagnostics+%3A+JMD&rft.au=Dubbink%2C+Hendrikus+J.&rft.au=Atmodimedjo%2C+Peggy+N.&rft.au=van+Marion%2C+Ronald&rft.au=Krol%2C+Niels+M.G.&rft.date=2016-09-01&rft.pub=Elsevier+Inc&rft.issn=1525-1578&rft.volume=18&rft.issue=5&rft.spage=775&rft.epage=786&rft_id=info:doi/10.1016%2Fj.jmoldx.2016.06.002&rft.externalDocID=S1525157816300903 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F15251578%2FS1525157816X00050%2Fcov150h.gif |